Resources>Citations Database>Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis B

Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis B

Biointron 2024-09-27

Authors: Lian Liu, Danyan Zhang, Rong Fan, Shipeng Cheng, Jichao Yang, Liyan Ma, Zhiyang Ling, Yaguang Zhang, Jinlin Hou, Xiaomei Wang, Bing Sun & Junqi Niu

Journal: Science China Life Sciences

PubMed ID: 39348048

DOI: https://doi.org/10.1007/s11427-024-2691-0

Products & Services: The ECM1 coding-region templates were synthesized by Biointron, codon-optimised for transcription/ translation in human cells and subcloned into the mammalian expression vector


Recommended Articles
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma
Nov 25, 2025
Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.